Skip to content
Trial Eligibility
Menu

THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation

NCT06395506

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The study's purpose is to evaluate whether creatine supplementation can help breast cancer survivors respond quicker to exercise by improving strength, endurance, and body composition. We are seeking to compare information collected from healthy woman of the same age who have never had breast cancer to those participants who have had breast cancer and undergone chemotherapy treatment.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer
  • Breast Cancer Female
  • Muscle Weakness

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 75 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
The University of Texas Medical Branch, Galveston
Last updated on ClinicalTrials.gov
December 24, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • The University of Texas Medical Branch, Galveston · Galveston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.